![Robert W. Anderson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert W. Anderson
Directeur/Membre du Conseil chez Humacyte Global, Inc.
Profil
Robert W.
Anderson is currently a Director at Humacyte Global, Inc. He previously worked as a Director at MicroIslet, Inc. Anderson received his undergraduate degree from Duke University and his MBA and doctorate degrees from Northwestern University.
Postes actifs de Robert W. Anderson
Sociétés | Poste | Début |
---|---|---|
Humacyte Global, Inc.
![]() Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | 01/01/2005 |
Anciens postes connus de Robert W. Anderson
Sociétés | Poste | Fin |
---|---|---|
MicroIslet, Inc.
![]() MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Formation de Robert W. Anderson
Duke University | Undergraduate Degree |
Northwestern University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
MicroIslet, Inc.
![]() MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Commercial Services |
Humacyte Global, Inc.
![]() Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |